Discovery of TKTL1Dr. Johannes Coy Discovers new universal biomarker at the German Institute for Cancer Research
Foundation of Zyagnum AGZyagnum is founded to develop a technology platform and diagnostic test for cancer
First in-house testThe first cancer-in-house test based on TKTL1 is launched in Germany - testing accuracy is not reliable and high enough for a commercial screening test
Development completedZyagnum finishes development of the unique EDIM technology and achieves registration of the PanTum Detect cancer screening test
PanTum DetectGlobal market launch & development of additional tests.